nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FMO3—Cimetidine—obesity	0.197	0.531	CbGbCtD
Dasatinib—CYP1A2—Phentermine—obesity	0.0236	0.0636	CbGbCtD
Dasatinib—CYP1A2—Phenylpropanolamine—obesity	0.0225	0.0607	CbGbCtD
Dasatinib—CYP1A2—Bupropion—obesity	0.0201	0.0541	CbGbCtD
Dasatinib—CYP3A5—Cimetidine—obesity	0.0198	0.0533	CbGbCtD
Dasatinib—CYP3A4—Sibutramine—obesity	0.0163	0.044	CbGbCtD
Dasatinib—CYP1A2—Cimetidine—obesity	0.0147	0.0397	CbGbCtD
Dasatinib—ABCB1—Cimetidine—obesity	0.0129	0.0347	CbGbCtD
Dasatinib—CYP3A4—Benzphetamine—obesity	0.0124	0.0333	CbGbCtD
Dasatinib—CYP3A4—Bupropion—obesity	0.0105	0.0283	CbGbCtD
Dasatinib—CYP3A4—Orlistat—obesity	0.00858	0.0231	CbGbCtD
Dasatinib—CYP3A4—Cimetidine—obesity	0.00772	0.0208	CbGbCtD
Dasatinib—CYP3A4—Topiramate—obesity	0.00506	0.0136	CbGbCtD
Dasatinib—STK36—pituitary gland—obesity	0.000516	0.00338	CbGeAlD
Dasatinib—STK36—adipose tissue—obesity	0.000513	0.00337	CbGeAlD
Dasatinib—BMPR1B—adrenal gland—obesity	0.000508	0.00333	CbGeAlD
Dasatinib—BTK—adrenal gland—obesity	0.000505	0.00332	CbGeAlD
Dasatinib—RIPK2—cardiovascular system—obesity	0.000503	0.0033	CbGeAlD
Dasatinib—SRC—islet of Langerhans—obesity	0.0005	0.00328	CbGeAlD
Dasatinib—LIMK2—pituitary gland—obesity	0.000498	0.00327	CbGeAlD
Dasatinib—TNK2—adrenal gland—obesity	0.000498	0.00327	CbGeAlD
Dasatinib—LIMK2—adipose tissue—obesity	0.000496	0.00326	CbGeAlD
Dasatinib—STAT5B—liver—obesity	0.000495	0.00325	CbGeAlD
Dasatinib—SIK3—endocrine gland—obesity	0.000494	0.00324	CbGeAlD
Dasatinib—YES1—respiratory system—obesity	0.000491	0.00322	CbGeAlD
Dasatinib—EPHB3—digestive system—obesity	0.000483	0.00317	CbGeAlD
Dasatinib—PDGFRA—respiratory system—obesity	0.000481	0.00316	CbGeAlD
Dasatinib—STK35—adipose tissue—obesity	0.000481	0.00316	CbGeAlD
Dasatinib—CSK—pituitary gland—obesity	0.00048	0.00315	CbGeAlD
Dasatinib—CSK—adipose tissue—obesity	0.000478	0.00314	CbGeAlD
Dasatinib—HCK—pituitary gland—obesity	0.000474	0.00311	CbGeAlD
Dasatinib—FMO3—adrenal cortex—obesity	0.000473	0.0031	CbGeAlD
Dasatinib—SRC—respiratory system—obesity	0.000472	0.0031	CbGeAlD
Dasatinib—HCK—adipose tissue—obesity	0.000472	0.0031	CbGeAlD
Dasatinib—ABL2—pituitary gland—obesity	0.000471	0.00309	CbGeAlD
Dasatinib—ABL2—adipose tissue—obesity	0.000469	0.00308	CbGeAlD
Dasatinib—TESK1—adrenal gland—obesity	0.000468	0.00307	CbGeAlD
Dasatinib—EPHB4—adrenal cortex—obesity	0.000466	0.00306	CbGeAlD
Dasatinib—EPHB3—adrenal gland—obesity	0.000461	0.00302	CbGeAlD
Dasatinib—STK36—adrenal gland—obesity	0.000461	0.00302	CbGeAlD
Dasatinib—ZAK—endocrine gland—obesity	0.000459	0.00301	CbGeAlD
Dasatinib—EPHA2—adrenal cortex—obesity	0.000457	0.003	CbGeAlD
Dasatinib—CSK—digestive system—obesity	0.00045	0.00295	CbGeAlD
Dasatinib—EPHA5—endocrine gland—obesity	0.000449	0.00295	CbGeAlD
Dasatinib—MAPK14—cardiovascular system—obesity	0.000448	0.00294	CbGeAlD
Dasatinib—LYN—endocrine gland—obesity	0.000447	0.00293	CbGeAlD
Dasatinib—FGR—cardiovascular system—obesity	0.000447	0.00293	CbGeAlD
Dasatinib—MAP3K3—adrenal cortex—obesity	0.000446	0.00293	CbGeAlD
Dasatinib—RIPK2—pituitary gland—obesity	0.000445	0.00292	CbGeAlD
Dasatinib—LIMK2—adrenal gland—obesity	0.000445	0.00292	CbGeAlD
Dasatinib—SIK3—liver—obesity	0.000445	0.00292	CbGeAlD
Dasatinib—HCK—digestive system—obesity	0.000444	0.00292	CbGeAlD
Dasatinib—RIPK2—adipose tissue—obesity	0.000444	0.00291	CbGeAlD
Dasatinib—BMPR1B—endocrine gland—obesity	0.00044	0.00289	CbGeAlD
Dasatinib—SIK1—pituitary gland—obesity	0.000435	0.00286	CbGeAlD
Dasatinib—SIK1—adipose tissue—obesity	0.000433	0.00284	CbGeAlD
Dasatinib—TNK2—endocrine gland—obesity	0.000432	0.00283	CbGeAlD
Dasatinib—STK35—adrenal gland—obesity	0.000432	0.00283	CbGeAlD
Dasatinib—EPHA4—pituitary gland—obesity	0.000431	0.00283	CbGeAlD
Dasatinib—EPHA4—adipose tissue—obesity	0.000429	0.00282	CbGeAlD
Dasatinib—CSK—adrenal gland—obesity	0.000429	0.00281	CbGeAlD
Dasatinib—EPHB4—cardiovascular system—obesity	0.000425	0.00279	CbGeAlD
Dasatinib—ERBB3—adipose tissue—obesity	0.000425	0.00279	CbGeAlD
Dasatinib—CSF1R—respiratory system—obesity	0.000424	0.00278	CbGeAlD
Dasatinib—HCK—adrenal gland—obesity	0.000423	0.00278	CbGeAlD
Dasatinib—JAK2—cardiovascular system—obesity	0.000422	0.00277	CbGeAlD
Dasatinib—ABL2—adrenal gland—obesity	0.000421	0.00276	CbGeAlD
Dasatinib—MAP3K2—adipose tissue—obesity	0.000421	0.00276	CbGeAlD
Dasatinib—RIPK2—digestive system—obesity	0.000418	0.00274	CbGeAlD
Dasatinib—EPHA2—cardiovascular system—obesity	0.000417	0.00274	CbGeAlD
Dasatinib—FYN—cardiovascular system—obesity	0.000416	0.00273	CbGeAlD
Dasatinib—ZAK—liver—obesity	0.000414	0.00272	CbGeAlD
Dasatinib—YES1—adrenal cortex—obesity	0.000412	0.0027	CbGeAlD
Dasatinib—MAP3K3—cardiovascular system—obesity	0.000407	0.00267	CbGeAlD
Dasatinib—TESK1—endocrine gland—obesity	0.000406	0.00266	CbGeAlD
Dasatinib—LYN—liver—obesity	0.000403	0.00265	CbGeAlD
Dasatinib—ERBB3—digestive system—obesity	0.0004	0.00262	CbGeAlD
Dasatinib—STK36—endocrine gland—obesity	0.000399	0.00262	CbGeAlD
Dasatinib—RIPK2—adrenal gland—obesity	0.000398	0.00261	CbGeAlD
Dasatinib—PDGFRB—islet of Langerhans—obesity	0.000398	0.00261	CbGeAlD
Dasatinib—MAPK14—pituitary gland—obesity	0.000397	0.00261	CbGeAlD
Dasatinib—FGR—pituitary gland—obesity	0.000395	0.0026	CbGeAlD
Dasatinib—MAPK14—adipose tissue—obesity	0.000395	0.0026	CbGeAlD
Dasatinib—BTK—liver—obesity	0.000395	0.00259	CbGeAlD
Dasatinib—FGR—adipose tissue—obesity	0.000394	0.00259	CbGeAlD
Dasatinib—LCK—adipose tissue—obesity	0.000394	0.00259	CbGeAlD
Dasatinib—TNK2—liver—obesity	0.000389	0.00256	CbGeAlD
Dasatinib—SIK1—adrenal gland—obesity	0.000389	0.00255	CbGeAlD
Dasatinib—LIMK2—endocrine gland—obesity	0.000386	0.00254	CbGeAlD
Dasatinib—KIT—respiratory system—obesity	0.000385	0.00253	CbGeAlD
Dasatinib—EPHA4—adrenal gland—obesity	0.000385	0.00253	CbGeAlD
Dasatinib—FMO3—pituitary gland—obesity	0.000382	0.00251	CbGeAlD
Dasatinib—FMO3—adipose tissue—obesity	0.00038	0.0025	CbGeAlD
Dasatinib—MAP3K2—adrenal gland—obesity	0.000377	0.00248	CbGeAlD
Dasatinib—EPHB4—pituitary gland—obesity	0.000376	0.00247	CbGeAlD
Dasatinib—PDGFRB—respiratory system—obesity	0.000376	0.00247	CbGeAlD
Dasatinib—EPHB4—adipose tissue—obesity	0.000375	0.00246	CbGeAlD
Dasatinib—STK35—endocrine gland—obesity	0.000374	0.00246	CbGeAlD
Dasatinib—JAK2—pituitary gland—obesity	0.000374	0.00245	CbGeAlD
Dasatinib—MAPK14—digestive system—obesity	0.000372	0.00244	CbGeAlD
Dasatinib—JAK2—adipose tissue—obesity	0.000372	0.00244	CbGeAlD
Dasatinib—CSK—endocrine gland—obesity	0.000372	0.00244	CbGeAlD
Dasatinib—FGR—digestive system—obesity	0.000371	0.00243	CbGeAlD
Dasatinib—EPHA2—pituitary gland—obesity	0.000369	0.00242	CbGeAlD
Dasatinib—FYN—pituitary gland—obesity	0.000369	0.00242	CbGeAlD
Dasatinib—PDGFRA—cardiovascular system—obesity	0.000369	0.00242	CbGeAlD
Dasatinib—EPHA2—adipose tissue—obesity	0.000368	0.00241	CbGeAlD
Dasatinib—FYN—adipose tissue—obesity	0.000367	0.00241	CbGeAlD
Dasatinib—HCK—endocrine gland—obesity	0.000367	0.00241	CbGeAlD
Dasatinib—TESK1—liver—obesity	0.000366	0.0024	CbGeAlD
Dasatinib—MAP2K5—adrenal cortex—obesity	0.000364	0.00239	CbGeAlD
Dasatinib—SRC—cardiovascular system—obesity	0.000361	0.00237	CbGeAlD
Dasatinib—MAP4K5—pituitary gland—obesity	0.00036	0.00236	CbGeAlD
Dasatinib—MAP3K3—pituitary gland—obesity	0.00036	0.00236	CbGeAlD
Dasatinib—STK36—liver—obesity	0.00036	0.00236	CbGeAlD
Dasatinib—MAP4K5—adipose tissue—obesity	0.000359	0.00236	CbGeAlD
Dasatinib—MAP3K3—adipose tissue—obesity	0.000359	0.00236	CbGeAlD
Dasatinib—CSF1R—adrenal cortex—obesity	0.000356	0.00233	CbGeAlD
Dasatinib—MAPK14—adrenal gland—obesity	0.000355	0.00233	CbGeAlD
Dasatinib—ABL1—islet of Langerhans—obesity	0.000355	0.00233	CbGeAlD
Dasatinib—FGR—adrenal gland—obesity	0.000353	0.00232	CbGeAlD
Dasatinib—LCK—adrenal gland—obesity	0.000353	0.00232	CbGeAlD
Dasatinib—EPHB4—digestive system—obesity	0.000353	0.00232	CbGeAlD
Dasatinib—JAK2—digestive system—obesity	0.00035	0.0023	CbGeAlD
Dasatinib—LIMK2—liver—obesity	0.000348	0.00229	CbGeAlD
Dasatinib—EPHA2—digestive system—obesity	0.000346	0.00227	CbGeAlD
Dasatinib—FYN—digestive system—obesity	0.000346	0.00227	CbGeAlD
Dasatinib—RIPK2—endocrine gland—obesity	0.000345	0.00227	CbGeAlD
Dasatinib—EPHB6—pituitary gland—obesity	0.000344	0.00226	CbGeAlD
Dasatinib—EPHB6—adipose tissue—obesity	0.000343	0.00225	CbGeAlD
Dasatinib—FMO3—adrenal gland—obesity	0.000341	0.00224	CbGeAlD
Dasatinib—STK35—liver—obesity	0.000337	0.00222	CbGeAlD
Dasatinib—SIK1—endocrine gland—obesity	0.000337	0.00221	CbGeAlD
Dasatinib—EPHB4—adrenal gland—obesity	0.000336	0.00221	CbGeAlD
Dasatinib—CSK—liver—obesity	0.000335	0.0022	CbGeAlD
Dasatinib—ABL1—respiratory system—obesity	0.000335	0.0022	CbGeAlD
Dasatinib—JAK2—adrenal gland—obesity	0.000334	0.00219	CbGeAlD
Dasatinib—EPHA4—endocrine gland—obesity	0.000334	0.00219	CbGeAlD
Dasatinib—YES1—pituitary gland—obesity	0.000333	0.00218	CbGeAlD
Dasatinib—MAP2K5—cardiovascular system—obesity	0.000332	0.00218	CbGeAlD
Dasatinib—YES1—adipose tissue—obesity	0.000331	0.00218	CbGeAlD
Dasatinib—HCK—liver—obesity	0.000331	0.00217	CbGeAlD
Dasatinib—ERBB3—endocrine gland—obesity	0.00033	0.00217	CbGeAlD
Dasatinib—EPHA2—adrenal gland—obesity	0.00033	0.00217	CbGeAlD
Dasatinib—FYN—adrenal gland—obesity	0.000329	0.00216	CbGeAlD
Dasatinib—ABL2—liver—obesity	0.000329	0.00216	CbGeAlD
Dasatinib—MAP3K2—endocrine gland—obesity	0.000327	0.00215	CbGeAlD
Dasatinib—PDGFRA—adipose tissue—obesity	0.000325	0.00213	CbGeAlD
Dasatinib—CSF1R—cardiovascular system—obesity	0.000324	0.00213	CbGeAlD
Dasatinib—MAP3K3—adrenal gland—obesity	0.000322	0.00211	CbGeAlD
Dasatinib—MAP4K5—adrenal gland—obesity	0.000322	0.00211	CbGeAlD
Dasatinib—SRC—adipose tissue—obesity	0.000319	0.00209	CbGeAlD
Dasatinib—PDGFRB—adrenal cortex—obesity	0.000315	0.00207	CbGeAlD
Dasatinib—YES1—digestive system—obesity	0.000312	0.00205	CbGeAlD
Dasatinib—RIPK2—liver—obesity	0.000311	0.00204	CbGeAlD
Dasatinib—MAPK14—endocrine gland—obesity	0.000308	0.00202	CbGeAlD
Dasatinib—EPHB6—adrenal gland—obesity	0.000308	0.00202	CbGeAlD
Dasatinib—FGR—endocrine gland—obesity	0.000306	0.00201	CbGeAlD
Dasatinib—PDGFRA—digestive system—obesity	0.000306	0.00201	CbGeAlD
Dasatinib—SIK1—liver—obesity	0.000304	0.00199	CbGeAlD
Dasatinib—SRC—digestive system—obesity	0.0003	0.00197	CbGeAlD
Dasatinib—ERBB3—liver—obesity	0.000298	0.00196	CbGeAlD
Dasatinib—YES1—adrenal gland—obesity	0.000297	0.00195	CbGeAlD
Dasatinib—FMO3—endocrine gland—obesity	0.000296	0.00194	CbGeAlD
Dasatinib—MAP3K2—liver—obesity	0.000295	0.00194	CbGeAlD
Dasatinib—KIT—cardiovascular system—obesity	0.000295	0.00193	CbGeAlD
Dasatinib—MAP2K5—pituitary gland—obesity	0.000294	0.00193	CbGeAlD
Dasatinib—MAP2K5—adipose tissue—obesity	0.000293	0.00192	CbGeAlD
Dasatinib—EPHB4—endocrine gland—obesity	0.000292	0.00191	CbGeAlD
Dasatinib—PDGFRA—adrenal gland—obesity	0.000292	0.00191	CbGeAlD
Dasatinib—JAK2—endocrine gland—obesity	0.000289	0.0019	CbGeAlD
Dasatinib—PDGFRB—cardiovascular system—obesity	0.000288	0.00189	CbGeAlD
Dasatinib—CSF1R—pituitary gland—obesity	0.000287	0.00189	CbGeAlD
Dasatinib—CSF1R—adipose tissue—obesity	0.000286	0.00188	CbGeAlD
Dasatinib—EPHA2—endocrine gland—obesity	0.000286	0.00188	CbGeAlD
Dasatinib—SRC—adrenal gland—obesity	0.000286	0.00188	CbGeAlD
Dasatinib—FYN—endocrine gland—obesity	0.000286	0.00187	CbGeAlD
Dasatinib—CYP1B1—respiratory system—obesity	0.000284	0.00186	CbGeAlD
Dasatinib—ABL1—adrenal cortex—obesity	0.000281	0.00185	CbGeAlD
Dasatinib—MAP3K3—endocrine gland—obesity	0.000279	0.00183	CbGeAlD
Dasatinib—MAP4K5—endocrine gland—obesity	0.000279	0.00183	CbGeAlD
Dasatinib—MAPK14—liver—obesity	0.000277	0.00182	CbGeAlD
Dasatinib—FGR—liver—obesity	0.000276	0.00181	CbGeAlD
Dasatinib—LCK—liver—obesity	0.000276	0.00181	CbGeAlD
Dasatinib—CSF1R—digestive system—obesity	0.000269	0.00177	CbGeAlD
Dasatinib—FMO3—liver—obesity	0.000267	0.00175	CbGeAlD
Dasatinib—MAP2K5—adrenal gland—obesity	0.000263	0.00173	CbGeAlD
Dasatinib—EPHB4—liver—obesity	0.000263	0.00173	CbGeAlD
Dasatinib—JAK2—liver—obesity	0.000261	0.00171	CbGeAlD
Dasatinib—KIT—pituitary gland—obesity	0.000261	0.00171	CbGeAlD
Dasatinib—KIT—adipose tissue—obesity	0.00026	0.00171	CbGeAlD
Dasatinib—EPHA2—liver—obesity	0.000258	0.00169	CbGeAlD
Dasatinib—YES1—endocrine gland—obesity	0.000258	0.00169	CbGeAlD
Dasatinib—FYN—liver—obesity	0.000257	0.00169	CbGeAlD
Dasatinib—CSF1R—adrenal gland—obesity	0.000257	0.00169	CbGeAlD
Dasatinib—ABL1—cardiovascular system—obesity	0.000256	0.00168	CbGeAlD
Dasatinib—PDGFRB—pituitary gland—obesity	0.000255	0.00167	CbGeAlD
Dasatinib—PDGFRB—adipose tissue—obesity	0.000254	0.00167	CbGeAlD
Dasatinib—PDGFRA—endocrine gland—obesity	0.000253	0.00166	CbGeAlD
Dasatinib—MAP3K3—liver—obesity	0.000252	0.00165	CbGeAlD
Dasatinib—MAP4K5—liver—obesity	0.000252	0.00165	CbGeAlD
Dasatinib—SRC—endocrine gland—obesity	0.000248	0.00163	CbGeAlD
Dasatinib—KIT—digestive system—obesity	0.000245	0.00161	CbGeAlD
Dasatinib—PDGFRB—digestive system—obesity	0.000239	0.00157	CbGeAlD
Dasatinib—KIT—adrenal gland—obesity	0.000233	0.00153	CbGeAlD
Dasatinib—YES1—liver—obesity	0.000232	0.00153	CbGeAlD
Dasatinib—MAP2K5—endocrine gland—obesity	0.000228	0.0015	CbGeAlD
Dasatinib—PDGFRA—liver—obesity	0.000228	0.0015	CbGeAlD
Dasatinib—PDGFRB—adrenal gland—obesity	0.000228	0.00149	CbGeAlD
Dasatinib—ABL1—pituitary gland—obesity	0.000227	0.00149	CbGeAlD
Dasatinib—ABL1—adipose tissue—obesity	0.000226	0.00149	CbGeAlD
Dasatinib—SRC—liver—obesity	0.000224	0.00147	CbGeAlD
Dasatinib—CSF1R—endocrine gland—obesity	0.000223	0.00146	CbGeAlD
Dasatinib—CYP1B1—cardiovascular system—obesity	0.000217	0.00143	CbGeAlD
Dasatinib—ABL1—digestive system—obesity	0.000213	0.0014	CbGeAlD
Dasatinib—CYP3A5—islet of Langerhans—obesity	0.000208	0.00136	CbGeAlD
Dasatinib—MAP2K5—liver—obesity	0.000206	0.00135	CbGeAlD
Dasatinib—CYP1A2—respiratory system—obesity	0.000203	0.00133	CbGeAlD
Dasatinib—ABL1—adrenal gland—obesity	0.000203	0.00133	CbGeAlD
Dasatinib—KIT—endocrine gland—obesity	0.000202	0.00133	CbGeAlD
Dasatinib—CSF1R—liver—obesity	0.000201	0.00132	CbGeAlD
Dasatinib—CYP1A1—respiratory system—obesity	0.0002	0.00132	CbGeAlD
Dasatinib—PDGFRB—endocrine gland—obesity	0.000197	0.0013	CbGeAlD
Dasatinib—CYP3A5—respiratory system—obesity	0.000196	0.00129	CbGeAlD
Dasatinib—CYP1B1—pituitary gland—obesity	0.000192	0.00126	CbGeAlD
Dasatinib—CYP1B1—adipose tissue—obesity	0.000192	0.00126	CbGeAlD
Dasatinib—Immune system disorder—Bupropion—obesity	0.000189	0.000928	CcSEcCtD
Dasatinib—Mediastinal disorder—Bupropion—obesity	0.000189	0.000926	CcSEcCtD
Dasatinib—Malaise—Sibutramine—obesity	0.000189	0.000926	CcSEcCtD
Dasatinib—Cough—Orlistat—obesity	0.000189	0.000925	CcSEcCtD
Dasatinib—Chills—Bupropion—obesity	0.000188	0.000922	CcSEcCtD
Dasatinib—Vertigo—Sibutramine—obesity	0.000188	0.000922	CcSEcCtD
Dasatinib—Syncope—Sibutramine—obesity	0.000188	0.00092	CcSEcCtD
Dasatinib—Convulsion—Orlistat—obesity	0.000187	0.000919	CcSEcCtD
Dasatinib—Arrhythmia—Bupropion—obesity	0.000187	0.000918	CcSEcCtD
Dasatinib—Face oedema—Topiramate—obesity	0.000186	0.000914	CcSEcCtD
Dasatinib—Alopecia—Bupropion—obesity	0.000185	0.000908	CcSEcCtD
Dasatinib—Palpitations—Sibutramine—obesity	0.000185	0.000907	CcSEcCtD
Dasatinib—Myalgia—Orlistat—obesity	0.000184	0.000903	CcSEcCtD
Dasatinib—Chest pain—Orlistat—obesity	0.000184	0.000903	CcSEcCtD
Dasatinib—Loss of consciousness—Sibutramine—obesity	0.000184	0.000902	CcSEcCtD
Dasatinib—Mental disorder—Bupropion—obesity	0.000184	0.0009	CcSEcCtD
Dasatinib—Anxiety—Orlistat—obesity	0.000183	0.0009	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000183	0.000897	CcSEcCtD
Dasatinib—Cough—Sibutramine—obesity	0.000183	0.000896	CcSEcCtD
Dasatinib—Malnutrition—Bupropion—obesity	0.000182	0.000895	CcSEcCtD
Dasatinib—KIT—liver—obesity	0.000182	0.0012	CbGeAlD
Dasatinib—Discomfort—Orlistat—obesity	0.000182	0.000892	CcSEcCtD
Dasatinib—Convulsion—Sibutramine—obesity	0.000181	0.000889	CcSEcCtD
Dasatinib—Blood creatinine increased—Topiramate—obesity	0.000181	0.000887	CcSEcCtD
Dasatinib—Hypertension—Sibutramine—obesity	0.000181	0.000886	CcSEcCtD
Dasatinib—CYP1B1—digestive system—obesity	0.00018	0.00118	CbGeAlD
Dasatinib—Dysgeusia—Bupropion—obesity	0.000179	0.000876	CcSEcCtD
Dasatinib—Chest pain—Sibutramine—obesity	0.000178	0.000874	CcSEcCtD
Dasatinib—Myalgia—Sibutramine—obesity	0.000178	0.000874	CcSEcCtD
Dasatinib—Arthralgia—Sibutramine—obesity	0.000178	0.000874	CcSEcCtD
Dasatinib—PDGFRB—liver—obesity	0.000178	0.00117	CbGeAlD
Dasatinib—Anxiety—Sibutramine—obesity	0.000178	0.000871	CcSEcCtD
Dasatinib—ABCG2—adrenal cortex—obesity	0.000177	0.00116	CbGeAlD
Dasatinib—Oedema—Orlistat—obesity	0.000176	0.000866	CcSEcCtD
Dasatinib—Discomfort—Sibutramine—obesity	0.000176	0.000863	CcSEcCtD
Dasatinib—ABL1—endocrine gland—obesity	0.000176	0.00116	CbGeAlD
Dasatinib—Hypokalaemia—Topiramate—obesity	0.000176	0.000861	CcSEcCtD
Dasatinib—Muscle spasms—Bupropion—obesity	0.000175	0.00086	CcSEcCtD
Dasatinib—Infection—Orlistat—obesity	0.000175	0.00086	CcSEcCtD
Dasatinib—Breast disorder—Topiramate—obesity	0.000174	0.000855	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Topiramate—obesity	0.000174	0.000852	CcSEcCtD
Dasatinib—Nervous system disorder—Orlistat—obesity	0.000173	0.000849	CcSEcCtD
Dasatinib—Confusional state—Sibutramine—obesity	0.000172	0.000845	CcSEcCtD
Dasatinib—Vision blurred—Bupropion—obesity	0.000172	0.000843	CcSEcCtD
Dasatinib—CYP1B1—adrenal gland—obesity	0.000172	0.00113	CbGeAlD
Dasatinib—Skin disorder—Orlistat—obesity	0.000171	0.000841	CcSEcCtD
Dasatinib—Tremor—Bupropion—obesity	0.000171	0.000838	CcSEcCtD
Dasatinib—Gastritis—Topiramate—obesity	0.000171	0.000838	CcSEcCtD
Dasatinib—Oedema—Sibutramine—obesity	0.000171	0.000838	CcSEcCtD
Dasatinib—Hyperhidrosis—Orlistat—obesity	0.000171	0.000837	CcSEcCtD
Dasatinib—Muscular weakness—Topiramate—obesity	0.00017	0.000835	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Topiramate—obesity	0.00017	0.000835	CcSEcCtD
Dasatinib—Infection—Sibutramine—obesity	0.00017	0.000832	CcSEcCtD
Dasatinib—Ill-defined disorder—Bupropion—obesity	0.000169	0.00083	CcSEcCtD
Dasatinib—Anaemia—Bupropion—obesity	0.000169	0.000827	CcSEcCtD
Dasatinib—Shock—Sibutramine—obesity	0.000168	0.000824	CcSEcCtD
Dasatinib—Abdominal distension—Topiramate—obesity	0.000168	0.000824	CcSEcCtD
Dasatinib—Thrombocytopenia—Sibutramine—obesity	0.000167	0.00082	CcSEcCtD
Dasatinib—Dysphagia—Topiramate—obesity	0.000167	0.000818	CcSEcCtD
Dasatinib—Asthma—Topiramate—obesity	0.000167	0.000818	CcSEcCtD
Dasatinib—Tachycardia—Sibutramine—obesity	0.000167	0.000818	CcSEcCtD
Dasatinib—Skin disorder—Sibutramine—obesity	0.000166	0.000814	CcSEcCtD
Dasatinib—Hyperhidrosis—Sibutramine—obesity	0.000165	0.00081	CcSEcCtD
Dasatinib—Malaise—Bupropion—obesity	0.000165	0.000807	CcSEcCtD
Dasatinib—Vertigo—Bupropion—obesity	0.000164	0.000804	CcSEcCtD
Dasatinib—Syncope—Bupropion—obesity	0.000164	0.000802	CcSEcCtD
Dasatinib—Pancreatitis—Topiramate—obesity	0.000164	0.000802	CcSEcCtD
Dasatinib—Anorexia—Sibutramine—obesity	0.000163	0.000798	CcSEcCtD
Dasatinib—Angina pectoris—Topiramate—obesity	0.000162	0.000797	CcSEcCtD
Dasatinib—Palpitations—Bupropion—obesity	0.000161	0.000791	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Orlistat—obesity	0.000161	0.000789	CcSEcCtD
Dasatinib—Loss of consciousness—Bupropion—obesity	0.00016	0.000786	CcSEcCtD
Dasatinib—Insomnia—Orlistat—obesity	0.00016	0.000783	CcSEcCtD
Dasatinib—Hypotension—Sibutramine—obesity	0.00016	0.000783	CcSEcCtD
Dasatinib—Cough—Bupropion—obesity	0.000159	0.000781	CcSEcCtD
Dasatinib—ABL1—liver—obesity	0.000159	0.00104	CbGeAlD
Dasatinib—Pancytopenia—Topiramate—obesity	0.000158	0.000777	CcSEcCtD
Dasatinib—Convulsion—Bupropion—obesity	0.000158	0.000775	CcSEcCtD
Dasatinib—Hypertension—Bupropion—obesity	0.000157	0.000772	CcSEcCtD
Dasatinib—Neutropenia—Topiramate—obesity	0.000156	0.000765	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Sibutramine—obesity	0.000156	0.000763	CcSEcCtD
Dasatinib—Dyspepsia—Orlistat—obesity	0.000155	0.000762	CcSEcCtD
Dasatinib—Myalgia—Bupropion—obesity	0.000155	0.000762	CcSEcCtD
Dasatinib—Arthralgia—Bupropion—obesity	0.000155	0.000762	CcSEcCtD
Dasatinib—Chest pain—Bupropion—obesity	0.000155	0.000762	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Topiramate—obesity	0.000155	0.00076	CcSEcCtD
Dasatinib—Anxiety—Bupropion—obesity	0.000155	0.000759	CcSEcCtD
Dasatinib—Insomnia—Sibutramine—obesity	0.000154	0.000758	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000154	0.000757	CcSEcCtD
Dasatinib—Pollakiuria—Topiramate—obesity	0.000154	0.000756	CcSEcCtD
Dasatinib—Discomfort—Bupropion—obesity	0.000153	0.000753	CcSEcCtD
Dasatinib—Decreased appetite—Orlistat—obesity	0.000153	0.000752	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Orlistat—obesity	0.000152	0.000747	CcSEcCtD
Dasatinib—Dyspnoea—Sibutramine—obesity	0.000152	0.000747	CcSEcCtD
Dasatinib—Photosensitivity reaction—Topiramate—obesity	0.000152	0.000747	CcSEcCtD
Dasatinib—Fatigue—Orlistat—obesity	0.000152	0.000746	CcSEcCtD
Dasatinib—Somnolence—Sibutramine—obesity	0.000152	0.000745	CcSEcCtD
Dasatinib—Weight increased—Topiramate—obesity	0.000152	0.000745	CcSEcCtD
Dasatinib—Weight decreased—Topiramate—obesity	0.000151	0.00074	CcSEcCtD
Dasatinib—Pain—Orlistat—obesity	0.000151	0.00074	CcSEcCtD
Dasatinib—Dyspepsia—Sibutramine—obesity	0.00015	0.000737	CcSEcCtD
Dasatinib—Confusional state—Bupropion—obesity	0.00015	0.000736	CcSEcCtD
Dasatinib—Pneumonia—Topiramate—obesity	0.00015	0.000734	CcSEcCtD
Dasatinib—CYP1B1—endocrine gland—obesity	0.000149	0.000978	CbGeAlD
Dasatinib—Oedema—Bupropion—obesity	0.000149	0.00073	CcSEcCtD
Dasatinib—Infestation NOS—Topiramate—obesity	0.000149	0.000729	CcSEcCtD
Dasatinib—Infestation—Topiramate—obesity	0.000149	0.000729	CcSEcCtD
Dasatinib—Decreased appetite—Sibutramine—obesity	0.000148	0.000728	CcSEcCtD
Dasatinib—Infection—Bupropion—obesity	0.000148	0.000725	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Sibutramine—obesity	0.000147	0.000723	CcSEcCtD
Dasatinib—Shock—Bupropion—obesity	0.000146	0.000718	CcSEcCtD
Dasatinib—Renal failure—Topiramate—obesity	0.000146	0.000717	CcSEcCtD
Dasatinib—Constipation—Sibutramine—obesity	0.000146	0.000716	CcSEcCtD
Dasatinib—Pain—Sibutramine—obesity	0.000146	0.000716	CcSEcCtD
Dasatinib—Nervous system disorder—Bupropion—obesity	0.000146	0.000716	CcSEcCtD
Dasatinib—Neuropathy peripheral—Topiramate—obesity	0.000146	0.000715	CcSEcCtD
Dasatinib—Thrombocytopenia—Bupropion—obesity	0.000146	0.000715	CcSEcCtD
Dasatinib—Feeling abnormal—Orlistat—obesity	0.000145	0.000713	CcSEcCtD
Dasatinib—Tachycardia—Bupropion—obesity	0.000145	0.000713	CcSEcCtD
Dasatinib—Stomatitis—Topiramate—obesity	0.000145	0.000711	CcSEcCtD
Dasatinib—Skin disorder—Bupropion—obesity	0.000145	0.000709	CcSEcCtD
Dasatinib—Conjunctivitis—Topiramate—obesity	0.000145	0.000709	CcSEcCtD
Dasatinib—Gastrointestinal pain—Orlistat—obesity	0.000144	0.000708	CcSEcCtD
Dasatinib—Hyperhidrosis—Bupropion—obesity	0.000144	0.000706	CcSEcCtD
Dasatinib—ABCG2—pituitary gland—obesity	0.000143	0.00094	CbGeAlD
Dasatinib—ABCG2—adipose tissue—obesity	0.000143	0.000936	CbGeAlD
Dasatinib—Anorexia—Bupropion—obesity	0.000142	0.000696	CcSEcCtD
Dasatinib—Haematuria—Topiramate—obesity	0.000142	0.000696	CcSEcCtD
Dasatinib—Feeling abnormal—Sibutramine—obesity	0.000141	0.00069	CcSEcCtD
Dasatinib—Epistaxis—Topiramate—obesity	0.00014	0.000688	CcSEcCtD
Dasatinib—Urticaria—Orlistat—obesity	0.00014	0.000688	CcSEcCtD
Dasatinib—Gastrointestinal pain—Sibutramine—obesity	0.00014	0.000685	CcSEcCtD
Dasatinib—Body temperature increased—Orlistat—obesity	0.000139	0.000684	CcSEcCtD
Dasatinib—Abdominal pain—Orlistat—obesity	0.000139	0.000684	CcSEcCtD
Dasatinib—Hypotension—Bupropion—obesity	0.000139	0.000682	CcSEcCtD
Dasatinib—Urticaria—Sibutramine—obesity	0.000136	0.000665	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Bupropion—obesity	0.000136	0.000665	CcSEcCtD
Dasatinib—CYP1A1—adipose tissue—obesity	0.000135	0.000889	CbGeAlD
Dasatinib—Abdominal pain—Sibutramine—obesity	0.000135	0.000662	CcSEcCtD
Dasatinib—Body temperature increased—Sibutramine—obesity	0.000135	0.000662	CcSEcCtD
Dasatinib—Insomnia—Bupropion—obesity	0.000135	0.00066	CcSEcCtD
Dasatinib—CYP1B1—liver—obesity	0.000134	0.000882	CbGeAlD
Dasatinib—Haemoglobin—Topiramate—obesity	0.000134	0.000658	CcSEcCtD
Dasatinib—Haemorrhage—Topiramate—obesity	0.000134	0.000655	CcSEcCtD
Dasatinib—Hepatitis—Topiramate—obesity	0.000134	0.000655	CcSEcCtD
Dasatinib—Dyspnoea—Bupropion—obesity	0.000133	0.000651	CcSEcCtD
Dasatinib—CYP3A5—adipose tissue—obesity	0.000132	0.000869	CbGeAlD
Dasatinib—Somnolence—Bupropion—obesity	0.000132	0.000649	CcSEcCtD
Dasatinib—Urinary tract disorder—Topiramate—obesity	0.000132	0.000647	CcSEcCtD
Dasatinib—Oedema peripheral—Topiramate—obesity	0.000132	0.000645	CcSEcCtD
Dasatinib—Connective tissue disorder—Topiramate—obesity	0.000131	0.000644	CcSEcCtD
Dasatinib—Dyspepsia—Bupropion—obesity	0.000131	0.000643	CcSEcCtD
Dasatinib—Urethral disorder—Topiramate—obesity	0.000131	0.000642	CcSEcCtD
Dasatinib—Hypersensitivity—Orlistat—obesity	0.00013	0.000638	CcSEcCtD
Dasatinib—Decreased appetite—Bupropion—obesity	0.000129	0.000635	CcSEcCtD
Dasatinib—CYP1A2—digestive system—obesity	0.000129	0.000848	CbGeAlD
Dasatinib—Visual impairment—Topiramate—obesity	0.000129	0.000631	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Bupropion—obesity	0.000129	0.00063	CcSEcCtD
Dasatinib—Fatigue—Bupropion—obesity	0.000128	0.00063	CcSEcCtD
Dasatinib—ABCG2—adrenal gland—obesity	0.000128	0.00084	CbGeAlD
Dasatinib—CYP1A1—digestive system—obesity	0.000127	0.000837	CbGeAlD
Dasatinib—Pain—Bupropion—obesity	0.000127	0.000624	CcSEcCtD
Dasatinib—Constipation—Bupropion—obesity	0.000127	0.000624	CcSEcCtD
Dasatinib—Asthenia—Orlistat—obesity	0.000127	0.000621	CcSEcCtD
Dasatinib—Erythema multiforme—Topiramate—obesity	0.000126	0.000619	CcSEcCtD
Dasatinib—Hypersensitivity—Sibutramine—obesity	0.000126	0.000617	CcSEcCtD
Dasatinib—Pruritus—Orlistat—obesity	0.000125	0.000612	CcSEcCtD
Dasatinib—Eye disorder—Topiramate—obesity	0.000125	0.000612	CcSEcCtD
Dasatinib—CYP3A5—digestive system—obesity	0.000125	0.000818	CbGeAlD
Dasatinib—Tinnitus—Topiramate—obesity	0.000124	0.000611	CcSEcCtD
Dasatinib—Cardiac disorder—Topiramate—obesity	0.000124	0.000608	CcSEcCtD
Dasatinib—Flushing—Topiramate—obesity	0.000124	0.000608	CcSEcCtD
Dasatinib—Feeling abnormal—Bupropion—obesity	0.000123	0.000602	CcSEcCtD
Dasatinib—Asthenia—Sibutramine—obesity	0.000123	0.000601	CcSEcCtD
Dasatinib—Gastrointestinal pain—Bupropion—obesity	0.000122	0.000597	CcSEcCtD
Dasatinib—Angiopathy—Topiramate—obesity	0.000121	0.000594	CcSEcCtD
Dasatinib—Pruritus—Sibutramine—obesity	0.000121	0.000593	CcSEcCtD
Dasatinib—Diarrhoea—Orlistat—obesity	0.000121	0.000592	CcSEcCtD
Dasatinib—Immune system disorder—Topiramate—obesity	0.000121	0.000591	CcSEcCtD
Dasatinib—Mediastinal disorder—Topiramate—obesity	0.00012	0.00059	CcSEcCtD
Dasatinib—Chills—Topiramate—obesity	0.00012	0.000588	CcSEcCtD
Dasatinib—Urticaria—Bupropion—obesity	0.000118	0.00058	CcSEcCtD
Dasatinib—Alopecia—Topiramate—obesity	0.000118	0.000579	CcSEcCtD
Dasatinib—Body temperature increased—Bupropion—obesity	0.000118	0.000577	CcSEcCtD
Dasatinib—Abdominal pain—Bupropion—obesity	0.000118	0.000577	CcSEcCtD
Dasatinib—Mental disorder—Topiramate—obesity	0.000117	0.000574	CcSEcCtD
Dasatinib—Diarrhoea—Sibutramine—obesity	0.000117	0.000573	CcSEcCtD
Dasatinib—Dizziness—Orlistat—obesity	0.000117	0.000572	CcSEcCtD
Dasatinib—Malnutrition—Topiramate—obesity	0.000116	0.00057	CcSEcCtD
Dasatinib—Erythema—Topiramate—obesity	0.000116	0.00057	CcSEcCtD
Dasatinib—Dysgeusia—Topiramate—obesity	0.000114	0.000558	CcSEcCtD
Dasatinib—Dizziness—Sibutramine—obesity	0.000113	0.000554	CcSEcCtD
Dasatinib—Vomiting—Orlistat—obesity	0.000112	0.00055	CcSEcCtD
Dasatinib—Muscle spasms—Topiramate—obesity	0.000112	0.000548	CcSEcCtD
Dasatinib—Rash—Orlistat—obesity	0.000111	0.000546	CcSEcCtD
Dasatinib—Dermatitis—Orlistat—obesity	0.000111	0.000545	CcSEcCtD
Dasatinib—Headache—Orlistat—obesity	0.000111	0.000542	CcSEcCtD
Dasatinib—ABCB1—islet of Langerhans—obesity	0.00011	0.000724	CbGeAlD
Dasatinib—Hypersensitivity—Bupropion—obesity	0.00011	0.000538	CcSEcCtD
Dasatinib—Vision blurred—Topiramate—obesity	0.00011	0.000537	CcSEcCtD
Dasatinib—Tremor—Topiramate—obesity	0.000109	0.000534	CcSEcCtD
Dasatinib—Vomiting—Sibutramine—obesity	0.000109	0.000533	CcSEcCtD
Dasatinib—Ill-defined disorder—Topiramate—obesity	0.000108	0.000529	CcSEcCtD
Dasatinib—Rash—Sibutramine—obesity	0.000108	0.000528	CcSEcCtD
Dasatinib—Dermatitis—Sibutramine—obesity	0.000108	0.000528	CcSEcCtD
Dasatinib—Anaemia—Topiramate—obesity	0.000107	0.000527	CcSEcCtD
Dasatinib—Headache—Sibutramine—obesity	0.000107	0.000525	CcSEcCtD
Dasatinib—Asthenia—Bupropion—obesity	0.000107	0.000524	CcSEcCtD
Dasatinib—CYP1A2—endocrine gland—obesity	0.000107	0.000701	CbGeAlD
Dasatinib—Pruritus—Bupropion—obesity	0.000105	0.000517	CcSEcCtD
Dasatinib—CYP1A1—endocrine gland—obesity	0.000105	0.000692	CbGeAlD
Dasatinib—Nausea—Orlistat—obesity	0.000105	0.000514	CcSEcCtD
Dasatinib—Malaise—Topiramate—obesity	0.000105	0.000514	CcSEcCtD
Dasatinib—Vertigo—Topiramate—obesity	0.000104	0.000512	CcSEcCtD
Dasatinib—Syncope—Topiramate—obesity	0.000104	0.000511	CcSEcCtD
Dasatinib—ABCB1—respiratory system—obesity	0.000104	0.000684	CbGeAlD
Dasatinib—CYP3A5—endocrine gland—obesity	0.000103	0.000676	CbGeAlD
Dasatinib—Palpitations—Topiramate—obesity	0.000103	0.000504	CcSEcCtD
Dasatinib—Loss of consciousness—Topiramate—obesity	0.000102	0.000501	CcSEcCtD
Dasatinib—Diarrhoea—Bupropion—obesity	0.000102	0.0005	CcSEcCtD
Dasatinib—Nausea—Sibutramine—obesity	0.000101	0.000498	CcSEcCtD
Dasatinib—Cough—Topiramate—obesity	0.000101	0.000497	CcSEcCtD
Dasatinib—Convulsion—Topiramate—obesity	0.000101	0.000494	CcSEcCtD
Dasatinib—Hypertension—Topiramate—obesity	0.0001	0.000492	CcSEcCtD
Dasatinib—ABCG2—liver—obesity	0.0001	0.000657	CbGeAlD
Dasatinib—Arthralgia—Topiramate—obesity	9.89e-05	0.000485	CcSEcCtD
Dasatinib—Chest pain—Topiramate—obesity	9.89e-05	0.000485	CcSEcCtD
Dasatinib—Myalgia—Topiramate—obesity	9.89e-05	0.000485	CcSEcCtD
Dasatinib—Anxiety—Topiramate—obesity	9.86e-05	0.000484	CcSEcCtD
Dasatinib—Dizziness—Bupropion—obesity	9.85e-05	0.000483	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.83e-05	0.000482	CcSEcCtD
Dasatinib—Discomfort—Topiramate—obesity	9.78e-05	0.000479	CcSEcCtD
Dasatinib—CYP1A2—liver—obesity	9.63e-05	0.000632	CbGeAlD
Dasatinib—Confusional state—Topiramate—obesity	9.56e-05	0.000469	CcSEcCtD
Dasatinib—CYP1A1—liver—obesity	9.5e-05	0.000623	CbGeAlD
Dasatinib—Oedema—Topiramate—obesity	9.49e-05	0.000465	CcSEcCtD
Dasatinib—Vomiting—Bupropion—obesity	9.47e-05	0.000464	CcSEcCtD
Dasatinib—Infection—Topiramate—obesity	9.42e-05	0.000462	CcSEcCtD
Dasatinib—Rash—Bupropion—obesity	9.39e-05	0.00046	CcSEcCtD
Dasatinib—Dermatitis—Bupropion—obesity	9.38e-05	0.00046	CcSEcCtD
Dasatinib—CYP3A4—digestive system—obesity	9.35e-05	0.000614	CbGeAlD
Dasatinib—Shock—Topiramate—obesity	9.33e-05	0.000458	CcSEcCtD
Dasatinib—Headache—Bupropion—obesity	9.33e-05	0.000457	CcSEcCtD
Dasatinib—Nervous system disorder—Topiramate—obesity	9.3e-05	0.000456	CcSEcCtD
Dasatinib—Thrombocytopenia—Topiramate—obesity	9.29e-05	0.000456	CcSEcCtD
Dasatinib—CYP3A5—liver—obesity	9.28e-05	0.00061	CbGeAlD
Dasatinib—Tachycardia—Topiramate—obesity	9.26e-05	0.000454	CcSEcCtD
Dasatinib—Skin disorder—Topiramate—obesity	9.21e-05	0.000452	CcSEcCtD
Dasatinib—Hyperhidrosis—Topiramate—obesity	9.17e-05	0.00045	CcSEcCtD
Dasatinib—Anorexia—Topiramate—obesity	9.04e-05	0.000443	CcSEcCtD
Dasatinib—Hypotension—Topiramate—obesity	8.86e-05	0.000435	CcSEcCtD
Dasatinib—Nausea—Bupropion—obesity	8.84e-05	0.000434	CcSEcCtD
Dasatinib—ABCB1—adrenal cortex—obesity	8.74e-05	0.000574	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Topiramate—obesity	8.64e-05	0.000424	CcSEcCtD
Dasatinib—Insomnia—Topiramate—obesity	8.58e-05	0.000421	CcSEcCtD
Dasatinib—Dyspnoea—Topiramate—obesity	8.46e-05	0.000415	CcSEcCtD
Dasatinib—Somnolence—Topiramate—obesity	8.43e-05	0.000414	CcSEcCtD
Dasatinib—Dyspepsia—Topiramate—obesity	8.35e-05	0.00041	CcSEcCtD
Dasatinib—Decreased appetite—Topiramate—obesity	8.25e-05	0.000404	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Topiramate—obesity	8.19e-05	0.000402	CcSEcCtD
Dasatinib—Fatigue—Topiramate—obesity	8.18e-05	0.000401	CcSEcCtD
Dasatinib—Constipation—Topiramate—obesity	8.11e-05	0.000398	CcSEcCtD
Dasatinib—Pain—Topiramate—obesity	8.11e-05	0.000398	CcSEcCtD
Dasatinib—ABCB1—cardiovascular system—obesity	7.98e-05	0.000524	CbGeAlD
Dasatinib—Feeling abnormal—Topiramate—obesity	7.82e-05	0.000383	CcSEcCtD
Dasatinib—Gastrointestinal pain—Topiramate—obesity	7.76e-05	0.00038	CcSEcCtD
Dasatinib—CYP3A4—endocrine gland—obesity	7.73e-05	0.000507	CbGeAlD
Dasatinib—Urticaria—Topiramate—obesity	7.54e-05	0.00037	CcSEcCtD
Dasatinib—Body temperature increased—Topiramate—obesity	7.5e-05	0.000368	CcSEcCtD
Dasatinib—Abdominal pain—Topiramate—obesity	7.5e-05	0.000368	CcSEcCtD
Dasatinib—ABCB1—pituitary gland—obesity	7.06e-05	0.000464	CbGeAlD
Dasatinib—ABCB1—adipose tissue—obesity	7.03e-05	0.000462	CbGeAlD
Dasatinib—Hypersensitivity—Topiramate—obesity	6.99e-05	0.000343	CcSEcCtD
Dasatinib—CYP3A4—liver—obesity	6.97e-05	0.000458	CbGeAlD
Dasatinib—Asthenia—Topiramate—obesity	6.81e-05	0.000334	CcSEcCtD
Dasatinib—Pruritus—Topiramate—obesity	6.71e-05	0.000329	CcSEcCtD
Dasatinib—ABCB1—digestive system—obesity	6.62e-05	0.000435	CbGeAlD
Dasatinib—Diarrhoea—Topiramate—obesity	6.49e-05	0.000318	CcSEcCtD
Dasatinib—ABCB1—adrenal gland—obesity	6.31e-05	0.000414	CbGeAlD
Dasatinib—Dizziness—Topiramate—obesity	6.27e-05	0.000308	CcSEcCtD
Dasatinib—Vomiting—Topiramate—obesity	6.03e-05	0.000296	CcSEcCtD
Dasatinib—Rash—Topiramate—obesity	5.98e-05	0.000293	CcSEcCtD
Dasatinib—Dermatitis—Topiramate—obesity	5.98e-05	0.000293	CcSEcCtD
Dasatinib—Headache—Topiramate—obesity	5.94e-05	0.000291	CcSEcCtD
Dasatinib—Nausea—Topiramate—obesity	5.63e-05	0.000276	CcSEcCtD
Dasatinib—ABCB1—endocrine gland—obesity	5.47e-05	0.000359	CbGeAlD
Dasatinib—ABCB1—liver—obesity	4.93e-05	0.000324	CbGeAlD
Dasatinib—SRC—Immune System—STAT3—obesity	7.9e-07	2.9e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IGF1—obesity	7.9e-07	2.9e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKT2—obesity	7.9e-07	2.9e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GPX1—obesity	7.87e-07	2.89e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAPK8—obesity	7.87e-07	2.89e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AKT1—obesity	7.86e-07	2.89e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CETP—obesity	7.86e-07	2.89e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MYC—obesity	7.84e-07	2.88e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NCOA1—obesity	7.83e-07	2.88e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—obesity	7.82e-07	2.87e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—PIK3CA—obesity	7.81e-07	2.87e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—obesity	7.81e-07	2.87e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—obesity	7.8e-07	2.86e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—obesity	7.8e-07	2.86e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—obesity	7.79e-07	2.86e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SDC1—obesity	7.77e-07	2.85e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—obesity	7.77e-07	2.85e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—AKT1—obesity	7.76e-07	2.85e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—STK11—obesity	7.72e-07	2.83e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP19A1—obesity	7.72e-07	2.83e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAPK8—obesity	7.7e-07	2.83e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—obesity	7.7e-07	2.83e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CD36—obesity	7.67e-07	2.81e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—MYC—obesity	7.66e-07	2.81e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—INS—obesity	7.66e-07	2.81e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKR1C3—obesity	7.65e-07	2.81e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3CG—obesity	7.64e-07	2.81e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—obesity	7.64e-07	2.8e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—obesity	7.61e-07	2.79e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PIK3CD—obesity	7.59e-07	2.78e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAPK8—obesity	7.58e-07	2.78e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—obesity	7.57e-07	2.78e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SCARB1—obesity	7.53e-07	2.76e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—obesity	7.52e-07	2.76e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—obesity	7.51e-07	2.76e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SERPINE1—obesity	7.5e-07	2.75e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—obesity	7.49e-07	2.75e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MTOR—obesity	7.47e-07	2.74e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PIK3CB—obesity	7.47e-07	2.74e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—PIK3CA—obesity	7.45e-07	2.73e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—PIK3CA—obesity	7.42e-07	2.72e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MYC—obesity	7.42e-07	2.72e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—obesity	7.41e-07	2.72e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—obesity	7.4e-07	2.72e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—obesity	7.38e-07	2.71e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—AKT1—obesity	7.35e-07	2.7e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SREBF1—obesity	7.31e-07	2.68e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAPK8—obesity	7.3e-07	2.68e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TYK2—obesity	7.3e-07	2.68e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—STAT3—obesity	7.3e-07	2.68e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—obesity	7.28e-07	2.67e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—obesity	7.27e-07	2.67e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RHOA—obesity	7.24e-07	2.66e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—INS—obesity	7.24e-07	2.66e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—obesity	7.21e-07	2.65e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAPK8—obesity	7.21e-07	2.65e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—STAT3—obesity	7.19e-07	2.64e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AKT1—obesity	7.19e-07	2.64e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—AKT1—obesity	7.19e-07	2.64e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—COMT—obesity	7.18e-07	2.63e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—obesity	7.17e-07	2.63e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—AKT1—obesity	7.17e-07	2.63e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PIK3R1—obesity	7.16e-07	2.63e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—obesity	7.16e-07	2.63e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARA—obesity	7.13e-07	2.62e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—obesity	7.12e-07	2.61e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3CD—obesity	7.11e-07	2.61e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT2—obesity	7.11e-07	2.61e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARGC1A—obesity	7.08e-07	2.6e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GNB3—obesity	7.08e-07	2.6e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—HMOX1—obesity	7.05e-07	2.59e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—PIK3CA—obesity	7.04e-07	2.59e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—STAT3—obesity	7.04e-07	2.58e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—obesity	7.02e-07	2.58e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—AKT1—obesity	7.02e-07	2.58e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—AKT1—obesity	6.99e-07	2.56e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—FASN—obesity	6.96e-07	2.55e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AKT1—obesity	6.93e-07	2.54e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—STAT3—obesity	6.93e-07	2.54e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—BCHE—obesity	6.93e-07	2.54e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—obesity	6.92e-07	2.54e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—AKT1—obesity	6.91e-07	2.54e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AGT—obesity	6.91e-07	2.53e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GNAS—obesity	6.89e-07	2.53e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—MYC—obesity	6.78e-07	2.49e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—obesity	6.77e-07	2.48e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—obesity	6.76e-07	2.48e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOB—obesity	6.75e-07	2.48e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3CD—obesity	6.72e-07	2.47e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—obesity	6.72e-07	2.47e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3R1—obesity	6.72e-07	2.47e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CAV1—obesity	6.7e-07	2.46e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOA1—obesity	6.69e-07	2.45e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2E1—obesity	6.69e-07	2.45e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MYC—obesity	6.68e-07	2.45e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—STAT3—obesity	6.68e-07	2.45e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—obesity	6.67e-07	2.45e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—AKT1—obesity	6.65e-07	2.44e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—PIK3CA—obesity	6.65e-07	2.44e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—obesity	6.63e-07	2.44e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—AKT1—obesity	6.62e-07	2.43e-06	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—AKT1—obesity	6.62e-07	2.43e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MTOR—obesity	6.61e-07	2.43e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PIK3CB—obesity	6.61e-07	2.43e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NQO1—obesity	6.61e-07	2.43e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—obesity	6.6e-07	2.42e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—STAT3—obesity	6.59e-07	2.42e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—obesity	6.57e-07	2.41e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—AKT1—obesity	6.57e-07	2.41e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MYC—obesity	6.54e-07	2.4e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—obesity	6.53e-07	2.4e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—PIK3CA—obesity	6.5e-07	2.39e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—obesity	6.49e-07	2.38e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—LPL—obesity	6.44e-07	2.37e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MYC—obesity	6.44e-07	2.36e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—obesity	6.43e-07	2.36e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—AKT1—obesity	6.38e-07	2.34e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—obesity	6.35e-07	2.33e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3R1—obesity	6.35e-07	2.33e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GCG—obesity	6.34e-07	2.33e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC2A4—obesity	6.34e-07	2.33e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAPK8—obesity	6.31e-07	2.32e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—PIK3CA—obesity	6.3e-07	2.31e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GPX1—obesity	6.29e-07	2.31e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYCS—obesity	6.25e-07	2.3e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—obesity	6.24e-07	2.29e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—PIK3CA—obesity	6.23e-07	2.29e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MYC—obesity	6.2e-07	2.28e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3CB—obesity	6.2e-07	2.28e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—obesity	6.19e-07	2.27e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—obesity	6.14e-07	2.25e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT1—obesity	6.14e-07	2.25e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT1—obesity	6.14e-07	2.25e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MYC—obesity	6.12e-07	2.25e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CD36—obesity	6.12e-07	2.25e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—obesity	6.11e-07	2.24e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3CG—obesity	6.11e-07	2.24e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AKT1—obesity	6.09e-07	2.23e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—AKT1—obesity	6.06e-07	2.23e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NCOA1—obesity	6.05e-07	2.22e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP19A1—obesity	5.96e-07	2.19e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—STK11—obesity	5.96e-07	2.19e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—obesity	5.89e-07	2.16e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—obesity	5.89e-07	2.16e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3CB—obesity	5.86e-07	2.15e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—obesity	5.81e-07	2.13e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—obesity	5.8e-07	2.13e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—obesity	5.8e-07	2.13e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PIK3CA—obesity	5.8e-07	2.13e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—INS—obesity	5.78e-07	2.12e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—STAT3—obesity	5.77e-07	2.12e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—obesity	5.76e-07	2.11e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PIK3CA—obesity	5.76e-07	2.11e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—AKT1—obesity	5.75e-07	2.11e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—obesity	5.75e-07	2.11e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARA—obesity	5.69e-07	2.09e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—PIK3CA—obesity	5.67e-07	2.08e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAPK8—obesity	5.59e-07	2.05e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—obesity	5.58e-07	2.05e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—PIK3CA—obesity	5.56e-07	2.04e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—COMT—obesity	5.54e-07	2.03e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—obesity	5.52e-07	2.03e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AGT—obesity	5.51e-07	2.02e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—PIK3CA—obesity	5.47e-07	2.01e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GNB3—obesity	5.46e-07	2e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARGC1A—obesity	5.46e-07	2e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HMOX1—obesity	5.44e-07	2e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AKT1—obesity	5.44e-07	2e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—obesity	5.4e-07	1.98e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3CD—obesity	5.37e-07	1.97e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MYC—obesity	5.36e-07	1.97e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAV1—obesity	5.35e-07	1.96e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—obesity	5.35e-07	1.96e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOA1—obesity	5.34e-07	1.96e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GNAS—obesity	5.32e-07	1.95e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—AKT1—obesity	5.31e-07	1.95e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—obesity	5.3e-07	1.94e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PIK3CA—obesity	5.28e-07	1.94e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—PIK3CA—obesity	5.27e-07	1.93e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOB—obesity	5.21e-07	1.91e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PIK3CA—obesity	5.2e-07	1.91e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AKT1—obesity	5.15e-07	1.89e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.11e-07	1.88e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—STAT3—obesity	5.11e-07	1.88e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—obesity	5.1e-07	1.87e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—AKT1—obesity	5.09e-07	1.87e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—obesity	5.07e-07	1.86e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3R1—obesity	5.07e-07	1.86e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—obesity	5.02e-07	1.84e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LPL—obesity	4.97e-07	1.83e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—obesity	4.92e-07	1.81e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3CG—obesity	4.87e-07	1.79e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GPX1—obesity	4.85e-07	1.78e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—obesity	4.84e-07	1.78e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MYC—obesity	4.75e-07	1.74e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—obesity	4.74e-07	1.74e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AKT1—obesity	4.74e-07	1.74e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CD36—obesity	4.72e-07	1.73e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—obesity	4.7e-07	1.73e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—AKT1—obesity	4.7e-07	1.73e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3CB—obesity	4.68e-07	1.72e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—obesity	4.66e-07	1.71e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—obesity	4.64e-07	1.7e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—obesity	4.64e-07	1.7e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AKT1—obesity	4.64e-07	1.7e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—INS—obesity	4.61e-07	1.69e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—obesity	4.6e-07	1.69e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PIK3CA—obesity	4.55e-07	1.67e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AKT1—obesity	4.54e-07	1.67e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—obesity	4.48e-07	1.64e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AKT1—obesity	4.47e-07	1.64e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARA—obesity	4.39e-07	1.61e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AKT1—obesity	4.31e-07	1.58e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AKT1—obesity	4.3e-07	1.58e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3CD—obesity	4.29e-07	1.57e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AGT—obesity	4.25e-07	1.56e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AKT1—obesity	4.25e-07	1.56e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—obesity	4.23e-07	1.55e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—obesity	4.17e-07	1.53e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAV1—obesity	4.13e-07	1.52e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOA1—obesity	4.12e-07	1.51e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3R1—obesity	4.05e-07	1.49e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—obesity	4.05e-07	1.49e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—obesity	4.03e-07	1.48e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PIK3CA—obesity	4.03e-07	1.48e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3CA—obesity	3.78e-07	1.39e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3CG—obesity	3.76e-07	1.38e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3CB—obesity	3.74e-07	1.37e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AKT1—obesity	3.72e-07	1.37e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—obesity	3.7e-07	1.36e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—obesity	3.63e-07	1.33e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—obesity	3.58e-07	1.31e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3CA—obesity	3.57e-07	1.31e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—obesity	3.57e-07	1.31e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—INS—obesity	3.56e-07	1.31e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3CD—obesity	3.31e-07	1.21e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKT1—obesity	3.29e-07	1.21e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—obesity	3.26e-07	1.2e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—obesity	3.12e-07	1.15e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3R1—obesity	3.12e-07	1.15e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AKT1—obesity	3.09e-07	1.13e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AKT1—obesity	2.92e-07	1.07e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3CB—obesity	2.88e-07	1.06e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—obesity	2.86e-07	1.05e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3CA—obesity	2.85e-07	1.05e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AKT1—obesity	2.33e-07	8.55e-07	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3CA—obesity	2.28e-07	8.36e-07	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AKT1—obesity	1.86e-07	6.83e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3CA—obesity	1.76e-07	6.45e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKT1—obesity	1.44e-07	5.27e-07	CbGpPWpGaD
